Phase II trial of ONO-4053 for the treatment of allergic rhinitis in Japan
Latest Information Update: 17 Mar 2016
Price :
$35 *
At a glance
- Drugs ONO 4053 (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- 07 Mar 2016 Results assessing effect of ONO-4053 on mast cell activation presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
- 19 May 2015 New trial record